Suppr超能文献

全外显子测序和疑似遗传性肾小管疾病患儿的变异谱:东印度 Tubulopathy 基因研究。

Whole-exome sequencing and variant spectrum in children with suspected inherited renal tubular disorder: the East India Tubulopathy Gene Study.

机构信息

Institute of Child Health, Kolkata, India.

Apollo Hospital, Kolkata, India.

出版信息

Pediatr Nephrol. 2022 Aug;37(8):1811-1836. doi: 10.1007/s00467-021-05388-y. Epub 2022 Jan 10.

Abstract

BACKGROUND

Inherited tubulopathies are a heterogeneous group of genetic disorders making whole-exome sequencing (WES) the preferred diagnostic methodology.

METHODS

This was a multicenter descriptive study wherein children (< 18 years) with clinically suspected tubular disorders were recruited for molecular testing through WES. Multiplex ligation-dependent probe amplification (MLPA) and Sanger sequencing were done when required. Variants were classified as per American College of Medical Genetics 2015 guidelines and pathogenic (P)/likely pathogenic (LP) variants were considered causative.

RESULTS

There were 77 index cases (male =73%). Median age at diagnosis was 48 months (IQR 18.5 to 108 months). At recruitment, the number of children in each clinical group was as follows: distal renal tubular acidosis (dRTA) = 25; Bartter syndrome = 18; isolated hypophosphatemic rickets (HP) = 6; proximal tubular dysfunction (pTD) = 12; nephrogenic diabetes insipidus (NDI) = 6; kidney stone/nephrocalcinosis (NC) = 6; others = 4. We detected 55 (24 novel) P/LP variants, providing genetic diagnoses in 54 children (70%). The diagnostic yield of WES was highest for NDI (100%), followed by HP (83%; all X-linked HP), Bartter syndrome (78%), pTD (75%), dRTA (64%), and NC (33%). Molecular testing had a definite impact on clinical management in 24 (31%) children. This included revising clinical diagnosis among 14 children (26% of those with a confirmed genetic diagnosis and 18% of the overall cohort), detection of previously unrecognized co-morbidities among 8 children (sensorineural deafness n = 5, hemolytic anemia n = 2, and dental changes n = 1) and facilitating specific medical treatment for 7 children (primary hyperoxaluria n = 1, cystinosis n = 4, tyrosinemia n = 2).

CONCLUSION

WES is a powerful tool in the diagnosis and management of children with inherited tubulopathies in the Indian population. A higher resolution version of the Graphical abstract is available as Supplementary information.

摘要

背景

遗传性肾小管疾病是一组异质性遗传疾病,全外显子组测序(WES)是首选的诊断方法。

方法

这是一项多中心描述性研究,通过 WES 对临床疑似管状疾病的儿童(<18 岁)进行分子检测。当需要时,进行多重连接依赖性探针扩增(MLPA)和 Sanger 测序。根据美国医学遗传学学院 2015 年指南对变异进行分类,并将致病性(P)/可能致病性(LP)变异视为致病原因。

结果

共有 77 名索引病例(男性=73%)。中位诊断年龄为 48 个月(IQR 18.5 至 108 个月)。在入组时,每个临床组的儿童人数如下:远端肾小管酸中毒(dRTA)=25;巴特综合征=18;孤立性低磷性佝偻病(HP)=6;近端肾小管功能障碍(pTD)=12;肾性尿崩症(NDI)=6;肾结石/肾钙质沉着症(NC)=6;其他=4。我们检测到 55 个(24 个新)P/LP 变异体,为 54 名儿童(70%)提供了遗传诊断。WES 的诊断率在 NDI 中最高(100%),其次是 HP(所有 X 连锁 HP 为 83%)、巴特综合征(78%)、pTD(75%)、dRTA(64%)和 NC(33%)。分子检测对 24 名(31%)儿童的临床管理有明确影响。这包括在 14 名儿童中修改临床诊断(占确诊遗传诊断儿童的 26%和整个队列的 18%)、在 8 名儿童中发现以前未识别的合并症(5 名感觉神经性耳聋、2 名溶血性贫血和 1 名牙齿变化),以及为 7 名儿童提供特定的药物治疗(1 名原发性高草酸尿症、4 名胱氨酸症、2 名酪氨酸血症)。

结论

WES 是印度人群遗传性肾小管疾病诊断和治疗的有力工具。图形摘要的更高分辨率版本可作为补充信息获得。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验